The Pricing and Reimbursement Environment for Immune Disease TherapiesDecision ResourcesJune 25, 2009 45 Pages - SKU: DECR2303149 |
|
541711 Research and Development In Biotechnology: State Industry Market Evaluator
6/1/2012 | published by: BizMiner
This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics are displayed for 2008-2009-2010 and 2011q2 for these measures:
|
more...
|
$699.00
|
|
Out-of-Pocket Healthcare 2012
4/3/2012 | published by: Kalorama Information
Despite numerous attempts to reign in costs of healthcare, consumers are increasingly paying for healthcare products and services from their own monies. The costs of health care products and services continue
|
more...
|
$995.00
|
|
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
4/30/2012 | published by: GBI Research
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments Summary GBI Research, the leading business intelligence provider, has released its latest
|
more...
|
$3,500.00
|
|
Mobilizing Patient Experience
4/25/2012 | published by: Compass Intelligence
This iDRD (Insight-based Data-Rich Deliverable) is part of the Health Care subscription. This 11-page report provides a brief look into how mHealth will transform patient care. Topics such as the mobile patient experience, key vendors,
|
more...
|
$1,500.00
|
|
Understanding India's Regional Health Markets
4/23/2012 | published by: Espicom Healthcare Intelligence
Critical information and statistics on national and regional health infrastructure and provision. An essential source of detailed key business data on this fast growing economy.
|
more...
|
$690.00
|
|
China Healthcare Market Forecast to 2015
5/1/2012 | published by: RNCOS
With the advancement of infrastructure, Chinese Healthcare Industry is entering into a new era of development. A large population-base along with increasing aging population, and continuously growing prevalence of lifestyle diseases are further supporting the
|
more...
|
$1,000.00
|
|
Industry Dynamics and Competitive Landscape in the South African Personal Accident and Health Insurance Industry to 2016: Market Profile
4/3/2012 | published by: Timetric
Synopsis The report provides top-level market analysis, information and insights into the South African personal accident and health insurance market, including: A description of the personal accident and health insurance market in South Africa The South African personal
|
more...
|
$1,000.00
|
|
Understanding Regional Chinese Health Markets
3/15/2012 | published by: Espicom Healthcare Intelligence
Critical information and statistics on national and regional health infrastructure and provision. An essential source of detailed key business data.
|
more...
|
$690.00
|
|
Saudi Arabian Healthcare Forecast to 2015
4/1/2012 | published by: RNCOS
Saudi Arabia represents the largest healthcare market in the GCC region that possesses a huge potential for further expansion due to rising healthcare needs. The government and health regulatory authorities in the country have been
|
more...
|
$1,200.00
|
|
U.S. Managed Markets: Driving Commercial Success through Outcomes-Based Reimbursement
3/1/2012 | published by: Cutting Edge Information
Win US Reimbursement and Build Payer Relationships
Global trends have pushed managed markets teams into a pivotal position in the US market, where reimbursement has never been more difficult. With concepts such as comparative
|
more...
|
$7,695.00
|
Related Markets
- Biotechnology
- General Biotechnology
- Diseases & Conditions
- Autoimmune
- Healthcare
- Insurance & Managed Care
Insurance & Managed Care Reports
- 6th Asian Pacific Congress of Heart Failure (APCHF) - Post-Conference Review and Analysis
- Global Infectious Disease Treatment Market 2011-2014
- Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs
- Analysis of the European Thrombosis Therapeutics Market
- Market Access in the United States: An Uncertain Outlook
